phone icon  Int'l : +1 (503) 505-6949
0
Shopping Cart is Empty..
$ 0

World Digital Pathology Market - Opportunities and Forecasts, 2012 - 2020

 Pages:83
pubn Published: Mar 2014
tab_nTables: 27
aut_nAuthor(s): Debbie Shields
 p_n

The digital pathology is a new technology that has digitalized the instruments used in the pathology labs for testing. The digitalization has led to the automation of the tests done during the diagnosis procedures. For example, a single digital instrument operated by a single pathologist can perform tests that were previously done using five instruments. The global digital pathology market, valued at $1.98 billion in 2012, is estimated to reach $5.7 billion by 2020. Automation in the conventional methods of pathology is the major driving force of this market, which has resulted in workflow efficiency, efficiency in analysis. Thus, resulting in fast and accurate results of the pathology tests. The other driving factors of this market are diagnosis that can be provided to patients in the remote regions and reduction in the cost of diagnosis. The cost includes procedure cost and the cost involved in delivery of the slides & data. The major limitation of the digital pathology market is the stringent regulations involved during the approval of digital pathology systems. The other limitation is the cost involved in the integration of DPS in the pathology labs. The challenges faced by the DP market are standardization and interoperability of the technology as the formats differ from region to region.

The digital pathology market is segmented into components, end users and geography. The products market consists of the Whole slide imaging (WSI), Image analysis- informatics and Storage, communication and integrated platforms. The WSI is the highest revenue generating market among the segments; however, image analysis-informatics market is expected to have the highest growth potential. The end users market is segmented into pharmaceutical research, clinical organizations and educational institutes. The pharmaceutical research is the highest revenue generating market and is also expected to have the highest growth potential. The geography market is dominated by the North American region, which is the highest revenue generating region; however, Asian market is expected to have the highest CAGR during the analysis period.

The key companies profiled in this report include Definiens AG, Digipath, Inc., Leica Microsystems Gmbh, Ventana medical systems, Inc., Nikon Corporation, Visiopharm, Philips healthcare, Indica Labs, Inc, Omnyx LLC and 3DHISTECH, Ltd.

digital pathology

KEY BENEFITS

  • In-depth analysis of the digital pathology market, which is segmented on the basis of products, end users and geographies are discussed in the report at a greater length
  • Quantitative analysis of the current market and estimations through 2013-2020, Thus helping digital pathology systems manufacturers to analyze the market
  • Assessment and ranking of the factors affecting the global market and their impact  on the digital pathology market
  • Study on the bargaining power of buyers and suppliers in the market, based on porter’s five force analysis. Thus helping digital pathology systems manufacturers to analyze the market
  • Analysis of trends in various geographic segments that would help the companies to plan their strategies depending on the region
  • SWOT and competitive analysis of the key players, which would help stakeholders to understand trends followed by their competitors and take actionable decisions.

KEY MARKET SEGMENTS

BY COMPONENTS

  • Whole slide imaging (WSI)
  • Image analysis- informatics
  • Storage, and communication and integrated platforms

BY END-USERS

  • Pharmaceutical research
  • Clinical organizations
  • Educational institutes

BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific
  • RoW

CHAPTER 1. INTRODUCTION

1.1 Key benefits
1.2 Key audiences
1.3 Research methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

CHAPTER 2. EXCECUTIVE SUMMARY

CHAPTER 3. GLOBAL DIGITAL PATHOLOGY MARKET OVERVIEW

3.1 Market definition and scope
3.2 Introduction
3.3 Conventional pathology Vs digital pathology
3.4 Image analysis and data retrieval
3.5 Management systems in digital pathology
3.6 Global access to data
3.7 Clinical trials using digital pathology
3.8 Information systems in digital pathology
3.9 Key findings

3.9.1 Top ten factors impacting digital pathology market
3.9.2 Top winning strategies in the digital pathology market
3.9.3 Top investment pockets in digital pathology market

3.9.3.1 Digital pathology market by product
3.9.3.2 Digital pathology market by end users

3.9.4 Porters Five Forces Analysis

3.9.4.1 Competition among the suppliers reduces the power of the suppliers
3.9.4.2 Availability of wide range of products enhances the buyers power
3.9.4.3 Emerging market creates high competition
3.9.4.4 Cost factor lowers the threat of new entrants
3.9.4.5 High cost encourages substitution

3.10 Reimbursement scenario
3.11 Regulatory issues
3.12 Case study

3.12.1 Case study: 1 digital pathology used in critical diagnosis
3.12.2 Case study: 2 examples and initiatives of deploying telepathology in emerging economies
3.12.3 Case study: 3 Role of digital pathology in saving cost of pharma companies

3.13 Market dynamics

3.13.1 Drivers

3.13.1.1 Cost efficiency
3.13.1.2 Ease in transportation
3.13.1.3 Efficient analysis
3.13.1.4 Raise in adoption
3.13.1.5 Efficiency in workflow
3.13.1.6 System efficiency
3.13.1.7 Diagnosis in remote regions
3.13.1.8 High efficiency

3.13.2 Restraints
3.13.3 Opportunities and challenges

CHAPTER 4. GLOBAL DIGITAL PATHOLOGY MARKET BY PRODUCTS

4.1 Global DP market by products, 2012-2020 ($Million)
4.2 Global DP products market by geography, 2012-2020 ($Million)
4.3 Whole slide imaging (WSI)

4.3.1 Global DP Whole slide imaging market by geography, 2012-202 ($Million)

4.4 Image analysis- informatics

4.4.1 Drivers

4.4.1.1 Helps in decision making
4.4.1.2 Automation to analyze numerous images
4.4.1.3 Compare image data with other data
4.4.1.4 To study complex morphologies and features

4.4.2 Global DP image analysis- informatics market by geography, 2012-2020 ($Million)

4.5 Storage, communication and information management systems

4.5.1 Global DP information management system ,storage & communication market by geography, 2012-2020 ($Million)

CHAPTER 5. GLOBAL DIGITAL PATHOLOGY MARKET BY END USERS

5.1 Global DP market by end users, 2012-2020 ($Million)
5.2 Global DP end user market by geography, 2012-2020 ($Million)
5.3 Pharmaceutical research

5.3.1 Global DP pharmaceutical research market by geography, 2012-2020 ($Million)

5.4 Clinical organizations

5.4.1 Global DP clinical organizations market by geography, 2012-2020 ($Million)

5.5 Educational institutes

5.5.1 Global DP educational institutes market by geography, 2012-202 ($Million)

CHAPTER 6. GLOBAL DIGITAL PATHOLOGY MARKET BY GEOGRAPHY

6.1 North America

6.1.1 North American DP market, 2012-2020 ($Million)

6.2 Europe

6.2.1 European DP market, 2012-2020 ($Million)

6.3 Asia

6.3.1 ASIAN DP market, 2012-2020, ($million)

6.4 RoW

6.4.1 RoW DP market, 2012-2020 ($Million)

CHAPTER 7. COMPANY PROFILES

7.1 Philips healthcare

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Strategic moves and developments
7.1.5 SWOT Analysis of Philips healthcare

7.2 Definiens AG

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Strategic moves and developments
7.2.4 Swot Analysis of Definiens

7.3 Digipath, Inc.

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Strategic moves and developments
7.3.4 Swot Analysis of Digipath, Inc.

7.4 Leica Microsystems Gmbh

7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Strategic moves and developments
7.4.4 Swot Analysis of Leica Microsystems

7.5 Ventana Medical systems, Inc.

7.5.1 Company overview:
7.5.2 Company snapshot
7.5.3 Strategic moves and developments
7.5.4 SWOT Analysis of Ventana Medical Systems, Inc.

7.6 Nikon Corporation

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Business performance
7.6.4 Strategic moves and developments
7.6.5 SWOT Analysis of Nikon Corporation

7.7 Visiopharm

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Strategic moves and developments
7.7.4 SWOT Analysis of Visiopharm

7.8 3DHISTECH

7.8.1 Company Overview
7.8.2 Company snapshot
7.8.3 Strategic moves and Development
7.8.4 Swot Analysis of 3DHISTECH

7.9 Indica labs

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Strategic moves and developments
7.9.4 SWOT Analysis of Indica Labs

7.10 Omnyx

7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Strategic moves and developments
7.10.4 SWOT Analysis of Omnyx, LLC.

LIST OF TABLES

TABLE 1 GLOBAL DP PRODUCTS MARKET BY GEOGRAPHY, 2012-2020($MILLIONS)
TABLE 2 GLOBAL DP MARKET BY PRODUCTS, 2012-2020 ($MILLION)
TABLE 3 GLOBAL DP PRODUCTS MARKET BY GEOGRAPHY, 2012-2020($MILLION)
TABLE 4 WHOLE SLIDE IMAGING SCANNERS BY VARIOUS COMPANIES
TABLE 5 GLOBAL DP WHOLE SLIDE IMAGING MARKET BY GEOGRAPHY, 2012-2020($MILLION)
TABLE 6 IMAGE ANALYSIS SOFWARE BY VARIOUS COMPANIES
TABLE 7 GLOBAL DP IMAGE ANALYSIS- INFORMATICS MARKET BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 8 GLOBAL DP INFORMATION MANAGEMENT SYSTEM ,STORAGE & COMMUNICATION MARKET BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 9 GLOBAL DP MARKET BY END USER, 2012-2020 ($MILLION)
TABLE 10 GLOBAL DP END USER MARKET BY GEOGRAPHY, 2012-2020($MILLION)
TABLE 11 GLOBAL DP PHARMACEUTICAL RESEARCH MARKET BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 12 GLOBAL DP CLINICAL ORGANIZATION MARKET BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 13 GLOBAL DP EDUCATIONAL INSTITUTES MARKET BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 14 NORTH AMERICAN DP MARKET, 2012-2020 ($MILLION)
TABLE 15 EUROPE DP MARKET, 2012-2020 ($MILLION)
TABLE 16 ASIAN DP MARKET, 2012-2020 ($MILLION)
TABLE 17 ROW DP MARKET, 2012-2020 ($MILLION)
TABLE 18 PHILIPS HEALTHCARE BUSINESS SNAPSHOT
TABLE 19 DEFINIENS BUSINESS SNAPSHOT
TABLE 20 DIGIPATH, INC BUSINESS SNAPSHOT
TABLE 21 LEICA MICROSYSTEMS BUSINESS SNAPSHOT
TABLE 22 VENTANA MEDICAL SYSTEMS, INC.BUSINESS SNAPSHOT
TABLE 23 NIKON CORPORATION BUSINESS SNAPSHOT
TABLE 24 VISIOPHARM BUSINESS SNAPSHOT
TABLE 25 3DHISTECH BUSINESS SNAPSHOT
TABLE 26 INDICA LABS BUSINESS SNAPSHOT
TABLE 27 OMNYX, LLC. BUSINESS SNAPSHOT

LIST OF FIGURES

FIG. 1 DIGITAL PATHOLOGY MARKET DEFINITION
FIG. 2 TOP FACTORS IMPACTING DIGITAL PATHOLOGY MARKET (2013-2020)
FIG. 3 TOP INVESTMENT MARKET BY PRODUCT
FIG. 4 TOP INVESTMENT MARKET BY END USER
FIG. 5 PORTERS FIVE FORCE ANALYSIS
FIG. 6 DIGITAL PATHOLOGY WORKFLOW
FIG. 7 STORAGE WORKFLOW
FIG. 8 CLOUD STORAGE SYSTEM
FIG. 9 REVENUE BY SALES IN BUSINESS UNITS, 2012
FIG. 10 SWOT ANALYSIS OF PHILIPS HEALTHCARE
FIG. 11 SWOT ANALYSIS OF DEFINIENS
FIG. 12 SWOT ANALYSIS OF DIGIPATH, INC
FIG. 13 SWOT ANALYSIS OF LEICA MICROSYSTEMS
FIG. 14 SWOT ANALYSIS OF VENTANA MEDICAL SYSTEMS, INC.
FIG. 15 REVENUE BY GEOGRAPHIC SALES , 2013
FIG. 16 REVENUE BY SALES IN BUSINESS UNITS, 2013
FIG. 17 SWOT ANALYSIS OF NIKON CORPORATION
FIG. 18 SWOT ANALYSIS OF VISIOPHARM
FIG. 19 SWOT ANALYSIS OF 3DHISTECH
FIG. 20 SWOT ANALYSIS OF INDICA LABS
FIG. 21 SWOT ANALYSIS OF OMNYX, LLC.

The digital pathology market is an emerging market that is used in the pathology field and is replacing the conventional pathology methods. The key reason for the adoption of the digital pathology system is its reduction in cost, fast and easy delivery of slides. Thus, helps in efficient analysis of the slide through DPS (digital pathology system). This also includes discussion with other pathologists during analysis.

The digital pathology market analyzed in this report includes the various products and the end users. The products market is segmented into Whole slide imaging (WSI), Image analysis- informatics and storage, communication and integrated platforms. This report excludes the in-depth analysis of the application market in digital pathology.

Digital pathology management system software makes archival and retrieval of data easy and in large volumes; thus, helping pathologists to analyze large volumes of data in project specific configurations. Data retrieval tools make it easy for the pathologists to access and search information on multiple criteria. The criteria are by specimen, digital image, case and subcategories such as scan date, type of stain used, etc. the system automatically applies complex algorithms to an entire slide to improve the image quality. This makes interpretation more objective, quantitative and accurate. Tedious analysis is simplified by automation achieved by the image analysis algorithms, such as estimating protein expression or cell counting. An algorithm simplifies the task that requires repetitiveness such as tissue classification, assay quantification and pattern recognition.

This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.

icon_01
SINGLE
USER
icon_02
GROUP LICENSE
Icon_03
SITE
LICENSE
Icon_04
GLOBAL LICENSE
$4515
$5325
$7350
$10680
SUPPORT
Delivery Formats
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Get This Report
buy now
First time buyer ?
Check offers and discount
on this report
GET DISCOUNT
Need More Information
phone_n +1 (503) 505-6949

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry. The market is poised to witness a remarkable growth, primarily due to the related technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures.
    Jun 2015 | Price: $4830(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Specialty enzymes have gained popularity in the recent years owing to their potential applications in various industries such as pharmaceutical, biotechnology research and diagnostics. Specialty enzymes are proteins that act as biocatalysts to accelerate reactions and produce the desired results in pharmaceuticals and diagnostics reactions.
    Aug 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Smart pill technology is a revolutionary technological innovation that has reduced the gap between healthcare and digital technology. Smart pills are basically medical devices and small embedded electronic appliances such as sensors, cameras and trackers.
    Aug 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Nonalcoholic Steatohepatitis (NASH) also known as silent disease is a type of fatty liver disease, which mainly affects people with diabetes and obesity. Symptoms of NASH are found among all demographics (from children to adults); however, they are more prevalent in younger people. Corner stage of cirrhosis is a form of NASH that can be reversed with proper medication.
    Aug 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    The Global Leukemia market involves acute and chronic conditions, namely acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia and chronic lymphocytic leukemia. Acute lymphoblastic leukemia is a hematological malignancy, which results in an abnormal increase in blood cells, i.e., immature WBCs (lymphoblast). It affects the blood, lymphoid system and bone marrow. It is believed that genetic and environmental factors are responsible for this group of cancers. Acute leukemia is more prevalent in infants; however, it can be also diagnosed in adults. A complete analysis of the global acute lymphoblastic leukemia therapeutics market provides various aspects of market research such as market trends, market drivers, restrains and opportunities.
    Oct 2015 | View Details >>
  • ...
    Sports medicine is a branch of medicine that deals with the prevention and treatment of injuries incurred during sports activities, exercises or physical fitness training. Sports medicine devices therefore, include a wide range of products utilized for the prevention, recovery and cure of injuries related to the above physical activities. These injuries consist of fractures, sprains, soft tissue damage, joint dislocation, strain and musculoskeletal injuries.
    Oct 2015 | View Details >>
  • ...
    The hospital assets management system helps to manage and protect hospital equipment. It uses automated software systems to monitor the environment in hospital campus. The technology solutions are becoming increasingly popular in the market due to rising concerns regarding security. It gives competitive edge to hospitals by positioning their premise as secure and monitored place. It also helps to comply with regulatory standards. The research assists stakeholders to identify most lucrative market segments so that appropriate business plan can be formulated.
    Oct 2015 | View Details >>
  • ...
    Digital Polymerase Chain Reaction (dPCR) is an advancement of traditional polymerase chain reaction (PCR). The traditional PCR with its limited precision and accuracy often fail to amplify small samples of nucleic acid to a detectable level. This has evoked a need of better techniques to assess the minute quantities of DNA or RNA.
    Oct 2015 | View Details >>